$1.2604
-0.0496[-3.79%]
At close: May 6
$1.2604
0[0.00%]
PreMarket: 5:09PM EDT
Aclaris Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aclaris Therapeutics using advanced sorting and filters.
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
---|
Aclaris Therapeutics (ACRS) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
The Actual EPS was $0.00, which beat the estimate of $-0.29.
The Actual Revenue was $0K, which missed the estimate of $1.4M.
Browse earnings estimates, EPS, and revenue on all stocks.